To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
304 Current news of Merckrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
Merck had a successful fiscal 2020, a year that was marked by the Covid-19 pandemic. The company increased its sales, expanded its EBITDA pre margin and met all the financial targets it had set for itself. The key drivers were the business with products and services for pharmaceutical ...
Merck strengthens site in Tempe as key strategic production and R&D hub for semiconductor materials in the United States
Merck announced an investment of €18 million at its site in Tempe, Arizona, USA. Merck previously leased the 28,000 square-meter facility from Lexington Tempe L.P. This investment gives Merck the flexibility to invest in its production facilities and strengthen its R&D capabilities in its global ...
Merck announced another milestone of its transformation program “Bright Future” for the business sector Performance Materials
Merck announced another milestone of its transformation program “Bright Future” for the business sector Performance Materials. With effect from February 1, 2021, Benjamin Hein will take over the role of General Manager and Head of Delivery Systems and Services, Greater China & Southeast Asia. He ...
Merck invests € 10 million in modular technical infrastructure
Merck announced a collaborative partnership with Siemens for the digitalization of production. This partnership is to result in the development of a process control system for the modular production of innovative materials and products for the electronics, pharmaceutical and life science ...
In comparison with the year-earlier quarter, Group net sales increased by 9.7% to € 4.4 billion
Merck grew significantly in the third quarter. In comparison with the year-earlier quarter, Group net sales increased by 9.7% to € 4.4 billion. The increase was primarily due to double-digit percentage organic growth in the Life Science business sector and acquisition-related increases in the ...
Additional OLED sublimation units will help meet customer demand in the growing OLED market of Asia
Merck announced a € 20 million expansion of its OLED (organic light-emitting diode) manufacturing capacity at its sites in Pyeongtaek, Korea and Shanghai, China. Additional sublimation units will be built to help meet customer demand in the growing OLED market. With the investment, Merck will ...
Two internationally experienced managers to join Executive Board
Stefan Oschmann will hand over the Chair of the Executive Board of Merck to Belén Garijo in 2021. The Board of Partners of E.MerckKG has appointed Garijo as new Chair of the Executive Board and CEO of Merck effective May 1, 2021. She is currently Vice Chair of the Executive Board and Deputy CEO ...
From today’s perspective targeted smaller to medium-sized acquisitions after 2022 more likely than major transformative deals
Merck expects to deliver continued profitable growth in the coming years despite a challenging market environment. Today at its virtual Capital Markets Day, the company presented to analysts and investors the progress made in realizing the growth and expansion phase of its strategy for the period ...
Healthcare and Performance Materials more strongly affected by the Covid-19 pandemic than Life Science
Merck registered the effects of the Covid-19 pandemic in all business sectors in the second quarter. Healthcare and Performance Materials were affected most strongly. In comparison with the year-earlier quarter, Group sales increased by 3.7% to € 4.1 billion. EBITDA pre, the Group’s most ...
Belén Garijo appointed Vice Chairman of the Executive Board and Deputy CEO
The Board of Partners of E.MerckKG appointed Belén Garijo as Vice Chairman of the Executive Board and Deputy CEO of Merck KGaA. She will maintain her current Executive Board responsibilities. “The appointment of Belén Garijo as Vice Chairman of the Executive Board and Deputy CEO recognizes her ...